#1706999 the Impact of Digital Twin Technology on HbA1c Reduction and ASCVD Risk in Participants Enrolled for Type 2 Diabetes Remission: Outcomes of RCCT at 1 Year

Paramesh Shamanna,Mala Dharmalingam,Arun Vadavi,Ashok Keshavamurthy,Mohamed Thajudeen,Suchitra Bhonsley,Shashank Joshi

Endocrine Practice（2024）

引用 0|浏览10

暂无评分

摘要

We evaluated the effectiveness of the digital twin (DT) technology to improve HbA1c and improve 10-year ASCVD risk, in patients enrolled to achieve remission of T2DM. DT platform uses AI and Internet of Things, to integrate multi-dimensional data to give precision nutrition and health recommendations via the mobile app.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要